CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) › Shareholders' EquityCHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2007: $1.91B2008: $1.24B2009: $688.73M2010: $527.36M2011: $527.36M2012: $603.20M2013: $644.08M2014: $675.93M2015: $737.56M2016: $839.12M2017: $1.05B2018: $1.32B2019: $1.64B2020: $2.12B2021: $2.54B2022: $2.98B2023: $3.60B2024: $3.47B2025: $3.17B$3.17B2007Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$3.17B-8.6%2024$3.47B-3.8%2023$3.60B+20.8%2022$2.98B+17.4%2021$2.54B+19.9%2020$2.12B+29.3%2019$1.64B+24.1%2018$1.32B+26.0%2017$1.05B+24.8%2016$839.12M+13.8%2015$737.56M+9.1%2014$675.93M+4.9%2013$644.08M+6.8%2012$603.20M+14.4%2011$527.36M+0.0%2010$527.36M-23.4%2009$688.73M-44.5%2008$1.24B-35.0%2007$1.91B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share